Descriptive and observational study in critically ill adult patients with data of systemic hyperinflammation and confirmed diagnosis of pneumonia due to COVID-19 by RT-PCR and pulmonary tomography with stay in the critical care unit of the General Hospital 71 of the Veracruz North delegation from the Mexican Social Security Institute who received tocilizumab from April to July 2020
